Literature DB >> 10544142

Open reading frame in rotavirus mRNA specifically promotes synthesis of double-stranded RNA: template size also affects replication efficiency.

J T Patton1, J Chnaiderman, E Spencer.   

Abstract

The 11 rotavirus mRNAs are capped, but not polyadenylated, have a high AU content, and serve as templates for the synthesis of double-stranded (ds)RNA. Earlier studies using a cell-free replication system showed that the 5'- and 3'-untranslated regions (UTRs) of the mRNAs have cis-acting signals that promote minus-strand synthesis. To identify additional factors that affect RNA replication, chimeric RNAs were made that consisted of portions of the gene 8 mRNA of SA11 rotavirus and of the gene for green fluorescent protein (gfp) or for the N protein of respiratory syncytial virus. Analysis of the chimeras in the cell-free replication system under noncompetitive conditions showed that the open reading frame (ORF) of viral mRNAs contains information that specifically promotes minus-strand synthesis. Results were also obtained indicating that a high AU content may increase the replication efficiency of RNAs and that, in general, an inverse correlation exists between replication efficiency and the length of the RNA template. Replication assays performed under competitive conditions showed that nonviral RNAs can interfere significantly with the replication of viral mRNAs, mostly likely by sequestering nonspecific RNA-binding proteins that are of limited concentration in the replication system and that are essential for dsRNA synthesis. In summary, rotavirus dsRNA synthesis is affected by many factors including cis-acting replication signals located in the 5'-UTR, 3'-UTR, and ORF of the mRNA as well as the size and possibly the AU content of the mRNA. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544142     DOI: 10.1006/viro.1999.9989

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  A human rotavirus with rearranged genes 7 and 11 encodes a modified NSP3 protein and suggests an additional mechanism for gene rearrangement.

Authors:  E Gault; N Schnepf; D Poncet; A Servant; S Teran; A Garbarg-Chenon
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Rearranged genomic RNA segments offer a new approach to the reverse genetics of rotaviruses.

Authors:  Cécile Troupin; Axelle Dehée; Aurélie Schnuriger; Patrice Vende; Didier Poncet; Antoine Garbarg-Chenon
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

3.  A base-specific recognition signal in the 5' consensus sequence of rotavirus plus-strand RNAs promotes replication of the double-stranded RNA genome segments.

Authors:  M Alejandra Tortorici; Bruce A Shapiro; John T Patton
Journal:  RNA       Date:  2005-11-21       Impact factor: 4.942

4.  Generation of genetically stable recombinant rotaviruses containing novel genome rearrangements and heterologous sequences by reverse genetics.

Authors:  Aitor Navarro; Shane D Trask; John T Patton
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

5.  De novo synthesis of minus strand RNA by the rotavirus RNA polymerase in a cell-free system involves a novel mechanism of initiation.

Authors:  D Chen; J T Patton
Journal:  RNA       Date:  2000-10       Impact factor: 4.942

6.  Rotavirus rearranged genomic RNA segments are preferentially packaged into viruses despite not conferring selective growth advantage to viruses.

Authors:  Cécile Troupin; Aurélie Schnuriger; Sarah Duponchel; Claire Deback; Nathalie Schnepf; Axelle Dehee; Antoine Garbarg-Chenon
Journal:  PLoS One       Date:  2011-05-17       Impact factor: 3.240

7.  Further characterisation of rotavirus cores: Ss(+)RNAs can be packaged in vitro but packaging lacks sequence specificity.

Authors:  Ulrich Desselberger; James Richards; Luba Tchertanov; Jean Lepault; Andrew Lever; Oscar Burrone; Jean Cohen
Journal:  Virus Res       Date:  2013-10-01       Impact factor: 3.303

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.